Companies

Unicycive Therapeutics, Inc.

UNCY · CIK 0001766140 · operating

$7.03+1.44%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$150.22M
P/E
Fwd P/E1.19
PEG
P/S
P/B3.89
EV/EBITDA-3.42
EV/Rev

Profitability

Gross Margin
Op. Margin-4758.07%
Net Margin-5441.33%
ROE-494.27%
ROA-115.98%
FCF Margin-4244.00%

Financial Health

Current Ratio1.28
Debt/Equity3.26
Free Cash Flow-$28.65M
Div. Yield

Growth & Other

Revenue Growth0.00%
EPS Growth56.25%
Beta1.82
52W High$11
52W Low$3.71

About Unicycive Therapeutics, Inc.

Unicycive Therapeutics, Inc. (UNCY) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $144 million, Unicycive Therapeutics, Inc. is a micro-cap company. The stock currently trades at $7.03, up 1.44% today, with a 52-week range of $3.71–$11.00. The company trades at a forward P/E of 1.1x.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-0.56$-0.56+56.3%
2023$-1.28$-1.28-6.7%
2022$-1.20$-1.20-39.5%
2021$-0.86

Annual Reports (10-K) · 4 filings

Report DateFiledAccession Number
2024-12-312025-03-310001213900-25-025828SEC ↗
2023-12-312024-03-280001213900-24-027202SEC ↗
2022-12-312023-03-310001213900-23-024901SEC ↗
2021-12-312022-03-310001213900-22-016384SEC ↗